# Solesence, Inc. (SLSN)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/solesence-inc/ JSON: https://steadybase.io/company/solesence-inc.json Checked Nov 10, 2026. Latest filing read: Aug 19, 2026.

## Company

- Legal name: SOLESENCE, INC.
- Ticker: SLSN (Nasdaq)
- SEC CIK: 0000883107
- Industry: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
- Headquarters: Romeoville, IL
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: solesence.com
- LinkedIn: https://www.linkedin.com/company/solésence
- Next earnings date: Nov 10, 2026

## Key facts

- Revenue: $62.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/0001999371-26-007345-index.html
- Operating income: $1.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/0001999371-26-007345-index.html
- Net income: $1.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/0001999371-26-007345-index.html
- SG&A: $10.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/0001999371-26-007345-index.html
- Employees: 115 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm
- Shares outstanding: 70,647,045 as of Aug 19, 2026 (10-Q filed Aug 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126018231/0001999371-26-018231-index.html
- Auditor: Rsm Us LLP, Milwaukee, Wisconsin, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm

## Business

Solésence, along with its wholly owned subsidiary, Solésence, LLC (our “Solésence consumer products subsidiary”), is a leading innovator in scientifically driven health care solutions across beauty, health and wellness categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of health-enhancing products.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $62.1M | $1.6M | $1.8M | $10.4M |
| Dec 31, 2024 | $52.3M | $5.1M | $4.2M | $7.2M |
| Dec 31, 2023 | $37.3M | -$3.5M | -$4.4M | $7.5M |
| Dec 31, 2022 | $37.3M | -$2.3M | -$2.6M | $7.6M |
| Dec 31, 2021 | $29.5M | $2.6M | $2.3M | $3.9M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/solesence-inc.json

## Officers and directors

- Jess Jankowski, President and Chief Executive Officer. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm
- Kevin Cureton, President and Chief Executive Officer. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm
- Laura Riffner, Chief Financial Officer. LinkedIn: https://linkedin.com/in/laurariffner. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm
- Laura C. Riffner, Chief Financial Officer. Source: Form 3 filed Oct 6, 2025, https://www.sec.gov/Archives/edgar/data/883107/000095013025000152/0000950130-25-000152-index.htm

## Recent 8-K events

- Oct 5, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326006412/f8k_100526.htm
- Oct 2, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326006367/f8k_100226.htm
- Aug 21, 2026: Item 4.02, Non-reliance on previously issued financial statements; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326005702/f8k_082126.htm
- Aug 20, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326005676/f8k_082026.htm
- Jul 10, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326004582/f8k_071026.htm
- May 12, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326003273/f8k_051126.htm
- Apr 29, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326002802/f8k_042726.htm
- Mar 31, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326002061/f8k_033126.htm
- Dec 3, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184325007730/f8k_120225.htm
- Dec 1, 2025: Item 1.01, Entry into a material definitive agreement; Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/883107/000117184325007680/f8k_120125.htm

## Insider trades (Form 4)

- Dec 24, 2025: R. Janet Whitmore (Director) bought 2,500 shares, about $4,785. Source: https://www.sec.gov/Archives/edgar/data/883107/000119312525336020/0001193125-25-336020-index.htm
- Nov 19, 2025: R. Janet Whitmore (Director) bought 35,056 shares, about $63,274. Source: https://www.sec.gov/Archives/edgar/data/883107/000119312525315434/0001193125-25-315434-index.htm

## What management said

- "In the second quarter, our business focused on operational execution and financial discipline as we continue implementing our Transform and Transcend strategy" Kevin Cureton, President and Chief Executive Officer (8-K filed Aug 20, 2026). Source: https://www.sec.gov/Archives/edgar/data/883107/000117184326005676/exh_991.htm

## Latest filings

- 8-K filed Oct 5, 2026: https://www.sec.gov/Archives/edgar/data/883107/000117184326006412/f8k_100526.htm
- 10-K filed Mar 31, 2026: https://www.sec.gov/Archives/edgar/data/883107/000199937126007345/slsn-10k_123125.htm
- 10-Q filed Aug 19, 2026: https://www.sec.gov/Archives/edgar/data/883107/000199937126018231/slsn-10q_063026.htm
- DEF 14A filed Jul 30, 2025: https://www.sec.gov/Archives/edgar/data/883107/000199937125010280/slsn-def14a_082825.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/